Your browser doesn't support javascript.
loading
How long will it take to reduce gastric cancer incidence by eradicating Helicobacter pylori infection?
Osborn, John F; Cattaruzza, Maria S; Ferri, Anna M; De Angelis, Flora; Renzi, Davide; Marani, Alessandra; Vaira, Dino.
  • Osborn JF; Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy. john.osborn@uniroma1.it
Cancer Prev Res (Phila) ; 6(7): 695-700, 2013 Jul.
Article en En | MEDLINE | ID: mdl-23682077
ABSTRACT
Helicobacter pylori (H. pylori) is the most important risk factor for the development of gastric cancer. The objective of this article is to estimate how the number of clinically diagnosed cases caused by H. pylori would reduce in the years after the eradication of the infection from a population. It is assumed that the eradication of H. pylori will prevent the start of some new gastric tumors, but those that have passed the "point of no return" will continue to develop until diagnosed clinically. The observed reduction in the number of clinically diagnosed cases of gastric cancer will depend on the form and parameters of the distribution of the time t taken for tumor to develop into a clinical case after passing the "point of no return." This analysis assumes that the time t follows normal and log-normal distributions with means 5, 10, and 15 years. If the mean value of time t were 5 years, H. pylori caused cases should be almost eliminated after 10 years, whereas if the mean were 10 years, the number of cases should be halved. If the mean were 15 years, the reduction would only be about 15% after 10 years. The eradication of H. pylori from a population will reduce the incidence of gastric cancer, but the follow-up time needed to show and evaluate the reduction may be longer than that that has been used in studies published so far.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Helicobacter pylori / Infecciones por Helicobacter / Antibacterianos Tipo de estudio: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País como asunto: Europa Idioma: En Año: 2013 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Helicobacter pylori / Infecciones por Helicobacter / Antibacterianos Tipo de estudio: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País como asunto: Europa Idioma: En Año: 2013 Tipo del documento: Article